Complementary and Alternative Medicine Use in United States Adults With Liver Disease
Complementary and Alternative Medicine Use in United States Adults With Liver Disease
复制标题
DOI：
10.1097/mcg.0000000000000617
复制
发表时间：
2017-07-01
影响因子：
2.9
通讯作者：
Muir, Andrew J.
中科院分区：
文献类型：
--
作者：
Henson, Jacqueline B.;Brown, Cristal L.;Muir, Andrew J.
目的：描述美国成人肝病患者使用补充和替代药物(CAM)的情况。背景：美国成人肝病患者中使用CAM的流行率和模式尚未得到很好的描述。2012年全国健康访谈调查被认为是关于美国成年人使用CAM的最新和最全面的信息来源。研究：利用2012年全国健康访谈调查的结果，比较了患有肝病和没有肝病的成年人使用CAM的流行率、最常见的方式、使用CAM的原因、感知的益处、感知的帮助和重要性以及向医疗保健提供者披露CAM的情况。结果：在647名患有肝病的成年人中，41%的人报告前一年使用过CAM，而非肝病的成年人的这一比例为33%。最常见的方式是草药和补充剂(23%)，3%的受访者报告在过去30天内消费了潜在的肝脏毒性物质。只有一小部分CAM疗法专门用于肝病，其中牛奶蓟是最常见的。在有肝病的受访者中，CAM更常用于焦虑或抑郁、疲劳和药物使用。大多数人认为这些疗法改善了健康。近三分之一的治疗没有报告给医疗保健提供者，主要是因为提供者没有询问。结论：CaM的使用，特别是草药和补充剂，在美国患有肝病的成年人中很普遍。许多人没有向他们的供应商披露他们的CAM使用情况，尽管一些人使用了潜在的肝脏毒性物质。
Goals: To describe the complementary and alternative medicine (CAM) use in US adults with liver disease.Background: The prevalence and patterns of CAM use among US adults with liver disease have not been well characterized. The 2012 National Health Interview Survey is considered the most current and comprehensive source of information on CAM use in US adults.Study: Using the results of the 2012 National Health Interview Survey, the prevalence of CAM use, most common modalities used, reasons for CAM use, perceived benefits, perceived helpfulness and importance, and disclosure of CAM to health care providers were compared between adults with and without liver disease.Results: Of the 647 adults with liver disease, 41% reported using CAM in the prior year, compared with 33% of adults without liver disease. The most common modality was herbs and supplements (23%), and 3% of respondents reported consumption of a potentially hepatotoxic substance in the previous 30 days. Only a small proportion of CAM therapies were used specifically for liver disease, with milk thistle being the most common. Among respondents with liver disease, CAM was used more commonly for anxiety or depression, fatigue, and substance use. The majority believed that these therapies improved health. Nearly one-third of therapies were not reported to health care providers, mostly due to failure of the provider to ask.Conclusions: CAM use, particularly herbs and supplements, is prevalent among US adults with liver disease. Many do not disclose their CAM use to their providers, despite some using potentially hepatotoxic substances.